R&D Partner Content Cell & Gene Therapy Pricing & Reimbursement Summit Unlocking Patient Access to Affordable Advanced Therapies
R&D Partner Content 6th Allogeneic Cell Therapies Summit Driving Potency, Efficacy & Durability of Universal Cell Therapies
R&D Partner Content The 3rd Next-Generation Conjugates Summit is back! Driving Innovation and Pioneering Novel Payload & Format Conjugate Design
R&D Partner Content 6th Treg Directed Therapies Summit Get ready for the much-anticipated return of the 6th Treg-Directed Therapies Summit! This year promises an enhanced experience wi
R&D Partner Content 4th Gene Therapy for Muscular Disorders 2024 4th Gene Therapy for Muscular Disorders Summit (April 16-18, Boston)
R&D Partner Content 5th RNA Editing Summit 2024 Pioneering RNA Editing Drugs Towards Clinical Realities
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
